| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 09/12/2006 | US7105494 Viral and non-viral vectors as vehicles for delivering transgenes for treating bone pathologies |
| 09/12/2006 | US7105486 Administering L-lysine-d-amphetamine; attention deficit hyperactivity disorder; decreasing the bioavailability of amphetamine by intravenous or intranasal administration, further limiting their abuse liability. |
| 09/12/2006 | US7105346 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 09/12/2006 | US7105342 In vitro proliferation of pluripotent neural stem cell; obtain mammalian neural tissues, dissociate neural tissue into suspension, culture, passaging neural stem cell progeny to a second culture and propagate cells |
| 09/12/2006 | US7105333 Nucleic acid molecules encoding a transmembrane serine protease 9, the encoded polypeptides and methods based thereon |
| 09/12/2006 | US7105331 ICE/CED-3 like protease designated FMH-1 |
| 09/12/2006 | US7105324 Nucleic acid isolated from Tetrahymena which codes for a triterpenoid cyclase, its production, and use |
| 09/12/2006 | US7105316 Neisseria lactoferrin binding protein |
| 09/12/2006 | US7105291 Detecting sensitivity to kidney disease |
| 09/12/2006 | US7105170 comprises in vitro granuloma model containing fibroblasts for drug screening vaccines; kits |
| 09/12/2006 | US7105162 Peptide or protein from a pathogenic or tumor agent having immunomodulatory activity with an adjuvant capable of increasing the binding of the peptide to the cells of the individual or increasing the entry of the peptide into the cells; strengthening immunomodulatory activity; polyamino acids adjuvants |
| 09/12/2006 | US7105157 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA |
| 09/12/2006 | US7105156 Introducing into a cell a composition of p56RB protein, a fragment of the p56RB protein, and the gene encoding p56RB protein; altering cell cycle progression while maintaining cell viability; soluble in low concentrations of glycerol, enhancing pharmaceutical applications |
| 09/12/2006 | CA2346539C Compositions and methods for enhancing receptor-mediated cellular internalization |
| 09/08/2006 | WO2006093337A1 Preventive/therapeutic agent for cancer |
| 09/08/2006 | WO2006093157A1 Oligonucleotide derivative, probe for detection of gene, and dna chip |
| 09/08/2006 | WO2006093143A1 Model for nash or liver tumor, method for production of the model, method for screening of therapeutic agent for nash or liver tumor, method for analysis of mechanism for development of nash or liver tumorm, and agent for prevention or treatment of nash |
| 09/08/2006 | WO2006093108A1 Gene transfer agent |
| 09/08/2006 | WO2006093034A1 Mental disorder-related gene and use of the same |
| 09/08/2006 | WO2006047417A3 Detection of cannabinoid receptor biomarkers and uses thereof |
| 09/08/2006 | WO2006023211A3 Antigens targeted by pathogenic ai4 t cells in type 1 diabetes and uses thereof |
| 09/08/2006 | WO2005103713A3 Methods, compositions and compound assays for inhibiting amyloid-beta protein production |
| 09/08/2006 | WO2005059515A3 Method for treating neurological disorders |
| 09/08/2006 | WO2005006947A3 Cells for use in locating and targeting tumor cells |
| 09/08/2006 | CA2599875A1 Preventive/therapeutic agent for cancer |
| 09/08/2006 | CA2574088A1 Oligonucleotides comprising a modified or non-natural nucleobase |
| 09/07/2006 | US20060200869 Lentiviral vectors carrying synthetic bi-directional promoters and uses thereof |
| 09/07/2006 | US20060199947 Naturally-occurring variants of B7 proteins produced by alternative RNA splicing or alternative termination of full-length amino acid sequence; regulation of immune response in an animal; immunostimulants; anticarcinogenic agents, infections; antiallergens; antiinflammatory agents; veterinary medicine |
| 09/07/2006 | US20060199946 Apoptosis inducing agent and method for inducing apoptosis |
| 09/07/2006 | US20060199782 Gene therapy using a SYN3 and SYN3 homolog delivery enhancing agent with an interferon protein or an interferon gene delivery system; anticarcinogenic agents |
| 09/07/2006 | US20060199781 Assays based on BTF3 activity |
| 09/07/2006 | US20060199780 Methods for modulating T cell survival by modulating bcl-XL protein level |
| 09/07/2006 | US20060199779 Compositions and methods for short interfering nucleic acid inhibition of NAv1.8 |
| 09/07/2006 | US20060199778 Methods and products related to non-viral transfection |
| 09/07/2006 | US20060199777 Novel technology of intracellular delivery of dna oligonucleotides to improve drug activity |
| 09/07/2006 | US20060199772 Use of a proteasome inhibitor in the treatment of endothelial dysfunction and/or in a low-dose proteasome inhibitor therapy |
| 09/07/2006 | US20060199767 Contacting cardiac muscle cells with a neuregulin protein to activate the MAP kinase pathway in cardiac muscle cells and induce remodeling of cardiac muscle cell sarcomeric and cytoskeleton structures or cell-cell adhesions |
| 09/07/2006 | US20060199761 Insulin resistance improving agent |
| 09/07/2006 | US20060199195 Nucleic acid encoding Schwannomin-Binding-Proteins and products related thereto |
| 09/07/2006 | US20060199192 genetic probes modified at the 5' terminus by a functional group, which is linked to the nucleic acid through an activating leaving group and a tether, that provide for detectable or functional changes following their release from the modified nucleic acid; kits for detecting of nucleic acid sequences |
| 09/07/2006 | US20060199179 Method for diagnosis of colorectal tumors |
| 09/07/2006 | US20060198842 treating skeletal muscle atrophy with a corticotropin releasing factor 2 receptor (CRF2R) agonist such as Sauvagine, urocortin II or an antibody |
| 09/07/2006 | US20060198829 Differentiation of human mesenchymal stem cells to cardiac progenitor cells that promote cardiac repair |
| 09/07/2006 | US20060198828 Two nucleotides containing 5-methylcytosine, the first hybridizing to the promoter region of a bcl-2 gene and the second hybridizing to a different type of oncogene; anticarcinogenic agents for melanomas, pancreatic, colon, breast, bladder, lung, leukemia, prostate, lymphoma, and ovarian cancers |
| 09/07/2006 | US20060198826 Compositions for gene therapy of rheumatoid arthritis including a gene encoding an anti-angiogenic protein or parts thereof |
| 09/07/2006 | US20060198825 Reagents, methods and systems to suppress phospholamban expression |
| 09/07/2006 | US20060198823 Compositions and methods for treating viral infections |
| 09/07/2006 | US20060198820 Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders |
| 09/07/2006 | US20060198815 Pharmaceutical formulations for sustained release |
| 09/07/2006 | US20060198813 Substituted fullerene compositions and their use in treatment of shock |
| 09/07/2006 | DE10015906B4 Gerichteter Gentransfer in Thy-1-positive Zellen Targeted gene transfer in Thy-1-positive cells |
| 09/06/2006 | EP1698701A1 Use of MHC class II ligands as adjuvant for vaccination and lag-3 in cancer treatment |
| 09/06/2006 | EP1698697A2 SSD-containing protein, process for producing the same and use thereof |
| 09/06/2006 | EP1698695A2 Antisense oligonucleotides for the inhibition of expression of type I procollagen |
| 09/06/2006 | EP1698691A1 Growth factor mutants with improved biological activity |
| 09/06/2006 | EP1698347A2 hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination |
| 09/06/2006 | EP1697542A2 Compositions and methods of using apoptosis signaling kinase related kinase (askrk) |
| 09/06/2006 | EP1697536A2 Novel oligonucleotides and treating cardiac disorders by using the same |
| 09/06/2006 | EP1697529A1 Viral particles containing an alpha virus derived vector and method for preparing said viral particle |
| 09/06/2006 | EP1697517A1 Brachyspira pilosicoli 72kda outer-membrane protein and diagnostic and therapeutic uses thereof |
| 09/06/2006 | EP1697515A1 Dna-carrier conjugate |
| 09/06/2006 | EP1697511A2 Immunotherapy compositions, method of making and method of use thereof |
| 09/06/2006 | EP1697500A1 Stem cells |
| 09/06/2006 | EP1697499A2 Methods of treating cardiac disorders by suppressing the expression of the potassium inwardly-rectifying channel |
| 09/06/2006 | EP1697396A2 Mrna transfected antigen presenting cells |
| 09/06/2006 | EP1696995A2 Meth0ds of using hcn genes to treat cardiac arrhythmias |
| 09/06/2006 | EP1696964A1 Use of microparticles for antigen delivery |
| 09/06/2006 | EP1696950A2 Vaccine comprising an angiomotin or a polynucleotide encoding an angiomotin and its use for the treatment of angiogenic-related disorders |
| 09/06/2006 | EP1696895A1 Modulation of 5-ht2 receptors as a treatment for cardiovascular diseases |
| 09/06/2006 | EP1497439B1 Recombining viral vectors for the tetracycline-regulated expression of genes |
| 09/06/2006 | EP1326632B1 Proteasome inhibitors for the treatment of hepatitis virus infections |
| 09/06/2006 | EP1173224B1 Polyethyleneimine:dna formulations for aerosol delivery |
| 09/06/2006 | EP1127149B1 Cells for the production of helper dependent adenoviral vectors |
| 09/06/2006 | EP1088075B1 Aav structural protein, production and use thereof |
| 09/06/2006 | EP0815204B1 Method for treating tumors by alloactivated human donor lymphocytes |
| 09/06/2006 | EP0789762B1 Methods for the diagnosis of glaucoma |
| 09/06/2006 | CN1829799A Recombinant influenza vectors with a POLII promoter and ribozymes |
| 09/06/2006 | CN1829797A Compositions and methods for preventing and treating liver cirrhosis |
| 09/06/2006 | CN1829796A Novel full-length genomic rna of Japanese encephalitis virus, infectious jev cDNA therefrom, and use thereof |
| 09/06/2006 | CN1829523A Viral vectors |
| 09/06/2006 | CN1827768A Nucleic acid sequence for potentiating the expression of useful gene and method therefor |
| 09/06/2006 | CN1827172A Pig viral infectious disease gene recombined live vaccine using canine II type adenovirus as carrier and preparation process thereof |
| 09/06/2006 | CN1273593C Gene cloning of polyepitope antigen of hepatitis C virus and its coding sequence |
| 09/06/2006 | CN1273478C Novel nucleosides and oligonucleotide analogues |
| 09/06/2006 | CN1273476C Oligonucleotide analoguse |
| 09/06/2006 | CN1273196C Target directional confluent DNA vaccine for preventing caries and preparation method thereof |
| 09/05/2006 | US7102059 Isolated nucleic acid molecule containing one open reading frame; a nucleotide sequence, or a complementary sequence encoding proteins or polypeptides of Pseudomonas CEL and EEL genomic regions or hybridizes to a DNA molecule |
| 09/05/2006 | US7101995 Drug delivery to inhibit abnormal gene expression in mammalian cells; small interfering RNAs (siRNA) |
| 09/05/2006 | US7101993 Oligonucleotides containing 2′-O-modified purines |
| 09/05/2006 | US7101991 antisense hsp27 oligonucleotides or RNAi nucleotide inhibitors |
| 09/05/2006 | US7101990 Bax-responsive genes for drug target identification in yeast and fungi |
| 09/05/2006 | US7101979 Antibodies to antiangiogenic compositions and methods |
| 09/05/2006 | US7101977 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor |
| 09/05/2006 | US7101973 β-amyloid peptide-binding proteins and polynucleotides encoding the same |
| 09/05/2006 | US7101972 With binding specificity for target nucleotides containing one or GNN triplets; regulating gene expression |
| 09/05/2006 | US7101709 Detecting modulator of cell proliferation, differentiation, viability, phenotypes or activity; prepare culture, incubate with modulator, monitor adjustment in cell characteristics, adjustment in characteristics indicate modulator |
| 09/05/2006 | US7101708 Hematopoietic cell composition for use in transplantation |
| 09/05/2006 | US7101705 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA |
| 09/05/2006 | US7101704 Expressing a co-stimulatory molecule, treated with interferon- gamma, and modified to have an exogenous antigen fragment bound to MHCII; antigen is presented to initiate an immune response |
| 09/05/2006 | US7101689 Interleukin-18 binding proteins, their preparation and use |